A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan
2017 ◽
Vol 40
(7)
◽
pp. 433-446
2013 ◽
Vol 10
(10)
◽
pp. 572-574
◽
Keyword(s):
2013 ◽
Vol 11
(1)
◽
pp. 25
◽